Company Analysis

Atea Pharmaceuticals, Inc. (AVIR)

Nasdaq: AVIR · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2013
Grade6.5
◀ Past 7.1● Present 7.6▶ Future 5.1
5 est.

Who runs Atea Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Sommadossi Jean-Pierre
President, CEO, and Chairman. First filing Oct 2020, latest Feb 3, 2026, 3 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
17 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Corcoran AndreaChief Financial Officer, Executive Vice President, Legal and SecretaryOct 2020Mar 13, 2026none
Sommadossi Jean-PierrePresident, CEO, and ChairmanOct 2020Feb 3, 2026none
Foster WayneEVP, Chief Accounting OfficerOct 2020Feb 3, 2026none
Hammond Janet MjChief Development OfficerOct 2020Feb 3, 2026none
Horga Maria ArantxaChief Medical OfficerOct 2020Feb 3, 2026none
Vavricka JohnChief Commercial OfficerOct 2020Feb 3, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Adams Jerome M.directorMay 2021Jun 23, 2026none
Berger Franklin MdirectorOct 2020Jun 23, 2026none
Berman HowarddirectorJun 2025Jun 23, 2026none
Duncan Barbara GayledirectorOct 2020Jun 23, 2026none
Kirsch Arthur SdirectorFeb 2025Jun 23, 2026none
Lucidi BrunodirectorOct 2020Jun 23, 2026none
Murphy Polly A.directorOct 2020Jun 23, 2026none
Polsky BrucedirectorOct 2020Jun 23, 2026none
Earlier names on the record12, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton AVIR · research, not advice